| Novartis Pharma Schweiz AG - Exelon Patch 15, transdermales Pflaster |
| 58078 | | 05 | | Exelon Patch 15 | | transdermales Pflaster | | N06DA03 | | Rivastigmin | | 22.05.2013 | | |
|
| Composition |
| rivastigminum 27 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, Trägermaterial: poly(ethylenis terephthalas), Drucktinte (Beige): ad praeparationem pro 15 cm², cum liberatione 13.3 mg/24h. |
| Packungsbestandteile |
| Timbre transdermique | | | | | Principe actif | Concentr. |
|---|
| Rivastigmine | 27 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Rivastigmine | 27 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acrylic Adhesive | | | | Butylis Methacrylatis | | | | Cum Liberatione | 13.3mg / 24h | | | Dimeticone | | | | Drucktinte (Beige): ad Praeparationem | 15 cm | | | Int-Rac-Alpha-Tocopherolum | | | | Methylis Methacrylatis Polymerisatum | | | | Poly(Ethylenis Terephthalas) | | Trägermaterial | | Silicone Adhesive | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 30 pansement(s) | 53.24 | 73.45 | B | LS | Non | | 006 | 60 pansement(s) | 106.48 | 130.55 | B | LS | Non |
|
